Company intelligence / Profile preview
Piezo Therapeutics
Cumming, Georgia, United Statespiezotx.com ↗
- Ownership
- Private
- Employees
- ~10
- Development stage
- Preclinical
01
Overview
Demonstrated robust induction of humoral and cellular responses to infectious disease and cancer vaccines with increased tolerability in preclinical models. In human subjects, Piezopen was well accepted and shown to elicit superior tolerability compared to a hypodermic needle.
- Therapeutic areas
- OtherOncologyDermatologyInfectious Diseases
- Modalities
- RNADNANucleic acid medicines
- Industry
- Biotech
02
Drug pipeline
1 asset03
Partnerships
Global pharma and biotech companies
Beyond the preview
Go deeper on Piezo Therapeutics.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Piezo Therapeutics.